News FAMHP

There are 6 results found(s) based on your search criteria

1-6 from 6 results

The Heads of Medicines Agencies (HMA) has published a statement of intent related to the replacement of the eAFs by the CESSP. As outlined in the eSubmission Roadmap, the current Common European Submission Platform (CESP) and the EMA eSubmission Gateway will be integrated into a Single Submission

During the Christmas holidays, famhp will be closed from Monday 26 December 2016 until Friday 30 December 2016 included.

The unit Scientific-Technical Advice & Knowledge Management has the pleasure to invite all those who are interested to the morning workshop “Famhp & EMA initiatives to support innovative drug development: implementation of a National Innovation Office as part of the EU Innovation Network” organised by the federal agency for medicines & healthcare products (famhp) on Thursday 01/12/2016. This interactive workshop will be held at famhp’s offices in Brussels and is free of charge..

The federal agency for medicines and healthcare products (famhp) prepares the implementation of a National Innovation Office in order to promote and facilitate the research and development of new innovative medecines in Belgium. In this context famhp has developed a questionnaire, in order to fine-tune famhp’s current plans for implementing a National Innovation Office and to align the objectives of the Innovation Office to the current and future needs of SME’s and academia.

The federal agency for medicines and health products (famhp) published its annual report 2015.

The unit Scientific-Technical Advice & Knowledge Management has the pleasure to invite all those who are interested to the afternoon workshop “National & EU scientific regulatory support mechanisms and initiatives for innovation in drug development” organised by the federal agency for medicines & healthcare products (famhp) on Monday 02/05/2016.